William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 44,568 shares at $16.75 ($746K) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Open-market sale of $746k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.11 | 120 | $2K | 0.2% |
| 2 | $16.75 | 44,448 | $745K | 99.8% |
| Total | $16.75 avg | 44,568 | $746K | 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |